Our work provide strong evidence that activation of the nuclear receptor LRH-1/NR5a2 using a small chemical agonist, fulfill these requirements and reverts diabetes in several mouse models via an intricate cross talk between islet and immune cells (Figure 1). This evidence concerns the gene NR5A2 and diabetes mellitus.